Vanguard Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,957,730
Closed -$25M 4646
2023
Q1
$25M Buy
5,957,730
+386,319
+7% +$1.62M ﹤0.01% 2495
2022
Q4
$33.5M Buy
5,571,411
+785,388
+16% +$4.72M ﹤0.01% 2370
2022
Q3
$27.9M Buy
4,786,023
+409,584
+9% +$2.38M ﹤0.01% 2482
2022
Q2
$26.1M Buy
4,376,439
+777,024
+22% +$4.64M ﹤0.01% 2518
2022
Q1
$16.8M Buy
3,599,415
+228,600
+7% +$1.07M ﹤0.01% 2874
2021
Q4
$8.36M Sell
3,370,815
-305,189
-8% -$757K ﹤0.01% 3322
2021
Q3
$10.8M Buy
3,676,004
+9,800
+0.3% +$28.9K ﹤0.01% 3195
2021
Q2
$9.17M Buy
3,666,204
+620,892
+20% +$1.55M ﹤0.01% 3251
2021
Q1
$8.86M Buy
3,045,312
+83,000
+3% +$242K ﹤0.01% 3215
2020
Q4
$9.54M Buy
2,962,312
+126,182
+4% +$406K ﹤0.01% 3019
2020
Q3
$6.1M Buy
2,836,130
+687,082
+32% +$1.48M ﹤0.01% 3046
2020
Q2
$2.49M Hold
2,149,048
﹤0.01% 3369
2020
Q1
$1.98M Buy
2,149,048
+633,374
+42% +$583K ﹤0.01% 3318
2019
Q4
$2.4M Buy
1,515,674
+178,869
+13% +$283K ﹤0.01% 3398
2019
Q3
$1.11M Buy
1,336,805
+280,851
+27% +$234K ﹤0.01% 3626
2019
Q2
$907K Sell
1,055,954
-448,342
-30% -$385K ﹤0.01% 3699
2019
Q1
$1.46M Buy
1,504,296
+1,802
+0.1% +$1.75K ﹤0.01% 3534
2018
Q4
$1.1M Sell
1,502,494
-885,336
-37% -$649K ﹤0.01% 3542
2018
Q3
$5.16M Sell
2,387,830
-1,021
-0% -$2.21K ﹤0.01% 3226
2018
Q2
$11.9M Buy
2,388,851
+235,987
+11% +$1.18M ﹤0.01% 2813
2018
Q1
$8.4M Buy
2,152,864
+1,301,983
+153% +$5.08M ﹤0.01% 2907
2017
Q4
$2.28M Sell
850,881
-225,168
-21% -$603K ﹤0.01% 3386
2017
Q3
$3.43M Buy
1,076,049
+322,670
+43% +$1.03M ﹤0.01% 3247
2017
Q2
$2.49M Sell
753,379
-59,119
-7% -$196K ﹤0.01% 3317
2017
Q1
$3.41M Buy
812,498
+53,343
+7% +$224K ﹤0.01% 3200
2016
Q4
$3.06M Buy
759,155
+22,883
+3% +$92.2K ﹤0.01% 3224
2016
Q3
$2.76M Sell
736,272
-27,575
-4% -$103K ﹤0.01% 3274
2016
Q2
$2.6M Sell
763,847
-68,938
-8% -$234K ﹤0.01% 3275
2016
Q1
$4.43M Buy
832,785
+168,861
+25% +$897K ﹤0.01% 3027
2015
Q4
$8.17M Buy
663,924
+70,483
+12% +$867K ﹤0.01% 2750
2015
Q3
$8.66M Buy
593,441
+32,774
+6% +$478K ﹤0.01% 2682
2015
Q2
$10.9M Buy
560,667
+23,582
+4% +$460K ﹤0.01% 2628
2015
Q1
$9.72M Buy
537,085
+77,814
+17% +$1.41M ﹤0.01% 2661
2014
Q4
$10.8M Buy
459,271
+42,533
+10% +$1M ﹤0.01% 2506
2014
Q3
$10.1M Buy
416,738
+32,280
+8% +$781K ﹤0.01% 2491
2014
Q2
$10.8M Buy
384,458
+12,652
+3% +$356K ﹤0.01% 2473
2014
Q1
$12.6M Buy
371,806
+124,869
+51% +$4.25M ﹤0.01% 2378
2013
Q4
$4.74M Buy
246,937
+19,926
+9% +$383K ﹤0.01% 2827
2013
Q3
$3.72M Buy
227,011
+10,899
+5% +$179K ﹤0.01% 2893
2013
Q2
$2.27M Buy
+216,112
New +$2.27M ﹤0.01% 3018